Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
27%
ALSO IN PPH
PPH
26
HOLDINGS
57%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.4% | 10.1% | 7.4% |
|
MERCK & CO. INC. | 6.9% | 5.9% | 5.9% |
|
PFIZER INC | 7.4% | 4.6% | 4.6% |
|
ABBVIE INC | 7.0% | 4.4% | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 6.3% | 4.3% | 4.3% |
FTXH Overweight Relative to PPH
|
GILEAD SCIENCES INC | 3.9% |
|
AMGEN INC | 3.6% |
|
BIOGEN IDEC INC | 3.6% |
|
UNITED THERAPEUTICS CORP | 3.6% |
|
VIATRIS, INC. | 3.3% |
|
REGENERON PHARMACEUTICALS | 3.0% |
|
PFIZER INC | 2.8% |
|
ABBVIE INC | 2.6% |
 |
JAZZ PHARMACEUTICALS PLC | 2.5% |
|
EXELIXIS INC | 2.4% |
FTXH Underweight Relative to PPH
|
ELI LILLY & CO | -15.2% |
 |
NOVARTIS AG-ADR | -7.6% |
 |
NOVO-NORDISK A/S-SPONS ADR | -7.5% |
|
MCKESSON CORP | -4.7% |
 |
SANOFI-AVENTIS-ADR | -4.5% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.4% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.3% |
|
CENCORA INC | -3.9% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.9% |
|
JOHNSON & JOHNSON | -2.6% |